I. Galani

发表

Epidemiology and molecular characterisation of metallo-β-lactamase-producing Enterobacteriaceae in a university hospital Intensive Care Unit in Greece.

A. Armaganidis, E. Koratzanis, M. Souli, 2011, International journal of antimicrobial agents.

Antimicrobial activity of copper surfaces against carbapenemase-producing contemporary Gram-negative clinical isolates.

A. Armaganidis, G. Petrikkos, D. Plachouras, 2013, The Journal of antimicrobial chemotherapy.

The effect of maternal flora on Candida colonisation in the neonate

G. Samonis, I. Galani, Anthoula Filippidi, 2014, Mycoses.

Presence of plasmid-mediated quinolone resistance in Klebsiella pneumoniae and Escherichia coli isolates possessing blaVIM-1 in Greece.

M. Souli, I. Galani, Z. Chryssouli, 2010, International journal of antimicrobial agents.

In vitro evaluation of double‐carbapenem combinations against OXA‐48‐producing Klebsiella pneumoniae isolates using time‐kill studies

M. Souli, I. Galani, Konstantina Nafplioti, 2018, Journal of medical microbiology.

Epidemiology and resistance phenotypes of carbapenemase-producing Klebsiella pneumoniae in Greece, 2014 to 2016.

M. Souli, I. Galani, H. Giamarellou, 2018, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

Immunomodulatory intervention with interferon-γ in Escherichia coli pyelonephritis.

E. Giamarellos‐Bourboulis, G. Damoraki, I. Galani, 2014, The Journal of urology.

Does the Activity of the Combination of Imipenem and Colistin In Vitro Exceed the Problem of Resistance in Metallo-β-Lactamase-Producing Klebsiella pneumoniae Isolates?

M. Souli, I. Galani, Z. Chryssouli, 2009, Antimicrobial Agents and Chemotherapy.

Colistin/daptomycin: an unconventional antimicrobial combination synergistic in vitro against multidrug-resistant Acinetobacter baumannii.

G. Petrikkos, M. Souli, I. Galani, 2014, International journal of antimicrobial agents.

Mechanisms responsible for imipenem resistance among Pseudomonas aeruginosa clinical isolates exposed to imipenem concentrations within the mutant selection window.

M. Souli, I. Galani, H. Giamarellou, 2017, Diagnostic microbiology and infectious disease.

In Vitro Interactions of Antimicrobial Combinations with Fosfomycin against KPC-2-Producing Klebsiella pneumoniae and Protection of Resistance Development

Stefanos Boukovalas, M. Souli, I. Galani, 2011, Antimicrobial Agents and Chemotherapy.

Discrepancies between various methods in susceptibility testing and epidemiological analysis of Stenotrophomonas maltophilia clinical isolates.

M. Souli, I. Galani, H. Giamarellou, 2010, Central European journal of public health.

Colonisation with vancomycin- and linezolid-resistant Enterococcus faecium in a university hospital: molecular epidemiology and risk factor analysis.

N. Siafakas, V. Sakka, S. Tsiodras, 2009, International journal of antimicrobial agents.

In vitro synergism of beta-lactams with ciprofloxacin and moxifloxacin against genetically distinct multidrug-resistant isolates of Pseudomonas aeruginosa.

P. Sarafis, E. Giamarellos‐Bourboulis, I. Galani, 2008, International journal of antimicrobial agents.

Characterisation of macrolide-non-susceptible Streptococcus pneumoniae colonising children attending day-care centres in Athens, Greece during 2000 and 2003.

M. Souli, I. Galani, Z. Chryssouli, 2007, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Polymyxin Triple Combinations against Polymyxin-Resistant, Multidrug-Resistant, KPC-Producing Klebsiella pneumoniae

Brian T. Tsuji, Su Mon Aye, J. Li, 2020, Antimicrobial Agents and Chemotherapy.

Novel β-lactam-β-lactamase inhibitor combinations: expectations for the treatment of carbapenem-resistant Gram-negative pathogens

M. Souli, I. Galani, H. Giamarellou, 2019, Expert opinion on drug metabolism & toxicology.

Carbapenemase producing Klebsiella pneumoniae: implication on future therapeutic strategies

I. Galani, H. Giamarellou, I. Karaiskos, 2021, Expert review of anti-infective therapy.

Transferable plasmid mediating resistance to multiple antimicrobial agents in Klebsiella pneumoniae isolates in Greece.

E. Xirouchaki, I. Galani, H. Giamarellou, 2002, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Multifaceted mechanisms of colistin resistance revealed by genomic analysis of multidrug-resistant Klebsiella pneumoniae isolates from individual patients before and after colistin treatment.

Su Mon Aye, J. Li, T. Velkov, 2019, The Journal of infection.

Nationwide epidemiology of carbapenem resistant Klebsiella pneumoniae isolates from Greek hospitals, with regards to plazomicin and aminoglycoside resistance

M. Souli, I. Galani, H. Giamarellou, 2019, BMC Infectious Diseases.

Colistin susceptibility testing by Etest and disk diffusion methods.

E. Koratzanis, M. Souli, I. Galani, 2008, International journal of antimicrobial agents.

Time–kill effect of levofloxacin on multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii: synergism with imipenem and colistin

E. Giamarellos‐Bourboulis, I. Galani, A. Pistiki, 2014, European Journal of Clinical Microbiology & Infectious Diseases.

Emergence of extensively drug-resistant and pandrug-resistant Gram-negative bacilli in Europe.

M. Souli, I. Galani, H. Giamarellou, 2008, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

Diagnostic value of a semi-nested PCR for the diagnosis of mucormycosis and aspergillosis from paraffin-embedded tissue: A single center experience.

A. Spathis, S. Tsiodras, G. Petrikkos, 2016, Pathology, Research and Practice.

Colistin-resistant isolates of Klebsiella pneumoniae emerging in intensive care unit patients: first report of a multiclonal cluster.

A. Armaganidis, A. Antoniadou, E. Koratzanis, 2007, The Journal of antimicrobial chemotherapy.

In vitro activity of ceftolozane/tazobactam alone and in combination with amikacin against MDR/XDR Pseudomonas aeruginosa isolates from Greece.

E. Petinaki, A. Antoniadou, M. Souli, 2020, The Journal of antimicrobial chemotherapy.

Colonization and infection by colistin-resistant Gram-negative bacteria in a cohort of critically ill patients.

A. Armaganidis, G. Dimopoulos, D. Plachouras, 2011, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Interactions of Klebsiella pneumoniae with the Innate Immune System Vary in Relation to Clone and Resistance Phenotype

E. Giamarellos‐Bourboulis, G. Daikos, I. Galani, 2015, Antimicrobial Agents and Chemotherapy.

Characterization of 16S rRNA methylase genes in Enterobacterales and Pseudomonas aeruginosa in Athens Metropolitan area, 2015–2016

V. Baka, A. Antoniadou, M. Souli, 2020, European Journal of Clinical Microbiology & Infectious Diseases.

Emergence of ceftazidime-avibactam resistance through distinct genomic adaptations in KPC-2-producing Klebsiella pneumoniae of sequence type 39 during treatment

A. Antoniadou, M. Souli, I. Galani, 2020, European Journal of Clinical Microbiology & Infectious Diseases.

Emergence of ceftazidime-avibactam resistance through distinct genomic adaptations in KPC-2-producing Klebsiella pneumoniae of sequence type 39 during treatment

A. Antoniadou, M. Souli, I. Galani, 2020, European Journal of Clinical Microbiology & Infectious Diseases.

Evaluation of in vitro methods for testing tigecycline combinations against carbapenemase-producing K.pneumoniae isolates.

I. Galani, H. Giamarellou, I. Karaiskos, 2020, Journal of global antimicrobial resistance.

Dissemination of International Clone II Acinetobacter baumannii Strains Coproducing OXA-23 Carbapenemase and 16S rRNA Methylase ArmA in Athens, Greece.

V. Baka, A. Antoniadou, M. Souli, 2020, Microbial drug resistance.

Activity of Plazomicin (ACHN-490) against MDR clinical isolates of Klebsiella pneumoniae, Escherichia coli, and Enterobacter spp. from Athens, Greece

G. Petrikkos, G. Daikos, M. Souli, 2012, Journal of chemotherapy.

Stimulation of innate immunity by susceptible and multidrug‐resistant Pseudomonas aeruginosa: an in vitro and in vivo study

E. Giamarellos‐Bourboulis, D. Plachouras, I. Galani, 2004, Clinical and experimental immunology.

Evaluation of different laboratory tests for the detection of metallo-beta-lactamase production in Enterobacteriaceae.

D. Plachouras, M. Souli, I. Galani, 2008, The Journal of antimicrobial chemotherapy.

Emerging bacterial pathogens: Escherichia coli, Enterobacter aerogenes and Proteus mirabilis clinical isolates harbouring the same transferable plasmid coding for metallo-beta-lactamase VIM-1 in Greece.

E. Koratzanis, M. Souli, I. Galani, 2007, The Journal of antimicrobial chemotherapy.

Outbreak of KPC-2-producing Klebsiella pneumoniae endowed with ceftazidime-avibactam resistance mediated through a VEB-1-mutant (VEB-25), Greece, September to October 2019

A. Antoniadou, M. Souli, I. Galani, 2020, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

Comparison of direct antimicrobial susceptibility testing methods for rapid analysis of bronchial secretion samples in ventilator-associated pneumonia.

A. Armaganidis, A. Antoniadou, M. Souli, 2011, International journal of antimicrobial agents.

Multidrug-resistant Klebsiella pneumoniae: mechanisms of resistance including updated data for novel β-lactam-β-lactamase inhibitor combinations

I. Galani, H. Giamarellou, Ilias Karaskos, 2021, Expert review of anti-infective therapy.

In vivo transmission of a plasmid containing the KPC-2 gene in a single patient.

M. Souli, I. Galani, Z. Chryssouli, 2013, Journal of global antimicrobial resistance.

Nosocomial dissemination of Providencia stuartii isolates producing extended-spectrum β-lactamases VEB-1 and SHV-5, metallo-β-lactamase VIM-1, and RNA methylase RmtB.

M. Souli, I. Galani, H. Giamarellou, 2013, Journal of global antimicrobial resistance.

In vitro activity of rifaximin against isolates from patients with small intestinal bacterial overgrowth.

M. Pimentel, E. Giamarellos‐Bourboulis, I. Galani, 2014, International journal of antimicrobial agents.

Ceftazidime/avibactam in the era of carbapenemase-producing Klebsiella pneumoniae: experience from a national registry study.

Christos G Gogos, K. Arvaniti, G. Daikos, 2020, The Journal of antimicrobial chemotherapy.

Colistin: still a lifesaver for the 21st century?

M. Souli, I. Galani, H. Giamarellou, 2017, Expert opinion on drug metabolism & toxicology.

R2164 In vitro interaction of imipenem, sulbactam, colistin and rifampin on 18 imipenem-resistant Acinetobacter baumannii isolates

I. Galani, Z. Chryssouli, H. Giamarellou, 2007 .

Acquired carbapenemases in Gram-negative bacterial pathogens: detection and surveillance issues.

V. Miriagou, P. Nordmann, L. Peixe, 2010, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Characterization of a new integron containing bla(VIM-1) and aac(6')-IIc in an Enterobacter cloacae clinical isolate from Greece.

M. Souli, I. Galani, Z. Chryssouli, 2005, The Journal of antimicrobial chemotherapy.

An outbreak of infection due to beta-Lactamase Klebsiella pneumoniae Carbapenemase 2-producing K. pneumoniae in a Greek University Hospital: molecular characterization, epidemiology, and outcomes.

A. Armaganidis, A. Antoniadou, M. Souli, 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Chemical and UV mutagenesis in Zymomonas mobilis

M. A. Typas, I. Galani, 2004, Genetica.

In Vitro Activity of Oral Cephalosporins (Cefprozil and Cefixime) Against Ciprofloxacin-Resistant Enterobacteriaceae from Community-Acquired Urinary-Tract Infections

T. Tsaganos, E. Giamarellos‐Bourboulis, I. Galani, 2015, Infectious Diseases and Therapy.

The impact of multidrug resistance on the pathogenicity of Escherichia coli: an experimental study.

T. Tsaganos, E. Giamarellos‐Bourboulis, I. Galani, 2008, International journal of antimicrobial agents.

Growth requirements and the establishment of a chemically defined minimal medium inZymomonasmobilis

C. Drainas, I. Galani, N. A. Typas, 1985, Biotechnology Letters.

Efficacy of carbapenems against a metallo-β-lactamase-producing Escherichia coli clinical isolate in a rabbit intra-abdominal abscess model.

T. Tsaganos, E. Giamarellos‐Bourboulis, M. Souli, 2007, The Journal of antimicrobial chemotherapy.

Clinical experience of serious infections caused by Enterobacteriaceae producing VIM-1 metallo-beta-lactamase in a Greek University Hospital.

A. Armaganidis, M. Souli, I. Galani, 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

In Vitro Interaction of Colistin and Rifampin on Multidrug-Resistant Pseudomonas aeruginosa

E. Giamarellos‐Bourboulis, I. Galani, H. Giamarellou, 2003, Journal of chemotherapy.

Plasmid‐mediated quinolone resistance determinants among Gram‐negative bacteraemia isolates: a hidden threat

G. Petrikkos, M. Souli, I. Galani, 2017, Journal of medical microbiology.

Evaluation of CHROMagar™ KPC for the detection of carbapenemase-producing Enterobacteriaceae in rectal surveillance cultures.

A. Antoniadou, M. Souli, I. Galani, 2011, International journal of antimicrobial agents.

First identification of an Escherichia coli clinical isolate producing both metalloβ-lactamase VIM-2 and extended-spectrum β-lactamase IBC-1

M. Souli, I. Galani, Z. Chryssouli, 2004 .

Emergence of Klebsiella pneumoniae co-producing OXA-48, CTX-M-15, and ArmA in Greece.

M. Souli, I. Galani, G. Petrikkos, 2016, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Transposon mutagenesis and strain construction in Zymomonas mobilis

K. Pappas, I. Galani, K M Pappas, 1997, Journal of applied microbiology.

Detection of CTX-M-15 and CTX-M-33, a novel variant of CTX-M-15, in clinical Escherichia coli isolates in Greece.

M. Souli, I. Galani, Z. Chryssouli, 2007, International journal of antimicrobial agents.

In vitro activity of imipenem-relebactam against non-MBL carbapenemase-producing Klebsiella pneumoniae isolated in Greek hospitals in 2015–2016

A. Antoniadou, M. Souli, I. Galani, 2019, European Journal of Clinical Microbiology & Infectious Diseases.

Risk-factors and predictors of mortality in patients colonised with vancomycin-resistant enterococci.

N. Siafakas, V. Sakka, S. Tsiodras, 2008, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Association Between Candiduria and Candidemia: A Clinical and Molecular Analysis of Cases

I. Galani, M. Drogari-Apiranthitou, G. Petrikkos, 2017, Mycopathologia.

Lipid A profiling and metabolomics analysis of paired polymyxin-susceptible and -resistant MDR Klebsiella pneumoniae clinical isolates from the same patients before and after colistin treatment.

Su Mon Aye, J. Li, T. Velkov, 2020, The Journal of antimicrobial chemotherapy.

Genomic characterization of a KPC-23-producing Klebsiella pneumoniae ST258 clinical isolate resistant to ceftazidime-avibactam.

A. Antoniadou, M. Souli, I. Galani, 2019, Clinical Microbiology and Infection.

Mecillinam/clavulanate combination: a possible option for the treatment of community-acquired uncomplicated urinary tract infections caused by extended-spectrum β-lactamase-producing Escherichia coli.

G. Petrikkos, M. Souli, I. Galani, 2012, The Journal of antimicrobial chemotherapy.

Characterization of 16S rRNA methylase genes in Enterobacterales and Pseudomonas aeruginosa in Athens Metropolitan area, 2015–2016

V. Baka, A. Antoniadou, M. Souli, 2020, European Journal of Clinical Microbiology & Infectious Diseases.

In vitro activity of imipenem-relebactam against non-MBL carbapenemase-producing Klebsiella pneumoniae isolated in Greek hospitals in 2015–2016

A. Antoniadou, M. Souli, I. Galani, 2019, European Journal of Clinical Microbiology & Infectious Diseases.

Time–kill effect of levofloxacin on multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii: synergism with imipenem and colistin

E. Giamarellos‐Bourboulis, I. Galani, A. Pistiki, 2015, European Journal of Clinical Microbiology & Infectious Diseases.

Successful treatment of right-sided prosthetic valve endocarditis due to methicillin-resistant teicoplanin-heteroresistant Staphylococcus aureus with linezolid

M. Souli, I. Galani, Z. Chryssouli, 2005, European Journal of Clinical Microbiology and Infectious Diseases.

Comparative In Vitro Activity and Killing Effect of Trovafloxacin, DU-6859a, Levofloxacin and Sparfloxacin against Staphylococcus aureus

E. Giamarellos‐Bourboulis, I. Galani, H. Giamarellou, 1997 .

Endothelial Glycocalyx Integrity in Treatment-Naïve People Living with HIV before and One Year after Antiretroviral Treatment Initiation

V. Gorgoulis, S. Tsiodras, H. Triantafyllidi, 2023, Viruses.

Emergence of extensively drug-resistant and pandrug-resistant Gram-negative bacilli in Europe.

M. Souli, I. Galani, H. Giamarellou, 2008, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

Association Between Candiduria and Candidemia: A Clinical and Molecular Analysis of Cases

I. Galani, M. Drogari-Apiranthitou, G. Petrikkos, 2017, Mycopathologia.

Plazomicin

I. Galani, 2021, Reactions Weekly.

Diagnostic value of a semi-nested PCR for the diagnosis of mucormycosis and aspergillosis from paraffin-embedded tissue: A single center experience.

A. Spathis, S. Tsiodras, G. Petrikkos, 2016, Pathology, research and practice.

Sustained cell-mediated but not humoral responses in rituximab-treated rheumatic patients after vaccination against SARS-CoV-2

K. Thomas, D. Vassilopoulos, S. Tsiodras, 2023, Rheumatology.

Comparison of direct antimicrobial susceptibility testing methods for rapid analysis of bronchial secretion samples in ventilator-associated pneumonia.

A. Armaganidis, A. Antoniadou, M. Souli, 2011, International journal of antimicrobial agents.

In vitro activities of omadacycline, eravacycline, cefiderocol, apramycin, and comparator antibiotics against Acinetobacter baumannii causing bloodstream infections in Greece, 2020–2021: a multicenter study

A. Ferke, A. Antoniadou, I. Galani, 2023, European Journal of Clinical Microbiology & Infectious Diseases.

In vitro activity of apramycin (EBL-1003) in combination with colistin, meropenem, minocycline or sulbactam against XDR/PDR Acinetobacter baumannii isolates from Greece

M. Souli, I. Galani, I. Karaiskos, 2024, The Journal of antimicrobial chemotherapy.